FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DENND4C-RHOBTB2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DENND4C-RHOBTB2
FusionPDB ID: 22263
FusionGDB2.0 ID: 22263
HgeneTgene
Gene symbol

DENND4C

RHOBTB2

Gene ID

55667

23221

Gene nameDENN domain containing 4CRho related BTB domain containing 2
SynonymsC9orf55|C9orf55B|RAB10GEF|bA513M16.3DBC2|EIEE64|p83
Cytomap

9p22.1

8p21.3

Type of geneprotein-codingprotein-coding
DescriptionDENN domain-containing protein 4CDENN/MADD domain containing 4A pseudogeneDENN/MADD domain containing 4Crho-related BTB domain-containing protein 2deleted in breast cancer 2 gene protein
Modification date2020031320200313
UniProtAcc

Q5VZ89

Main function of 5'-partner protein: FUNCTION: Guanine nucleotide exchange factor (GEF) activating RAB10. Promotes the exchange of GDP to GTP, converting inactive GDP-bound RAB10 into its active GTP-bound form. Thereby, stimulates SLC2A4/GLUT4 glucose transporter-enriched vesicles delivery to the plasma membrane in response to insulin. {ECO:0000269|PubMed:20937701}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000380432, ENST00000434457, 
ENST00000602925, 
ENST00000523918, 
ENST00000251822, ENST00000519685, 
ENST00000522948, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score9 X 9 X 6=4863 X 4 X 2=24
# samples 124
** MAII scorelog2(12/486*10)=-2.01792190799726
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/24*10)=0.736965594166206
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: DENND4C [Title/Abstract] AND RHOBTB2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DENND4C [Title/Abstract] AND RHOBTB2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DENND4C(19357152)-RHOBTB2(22861938), # samples:2
DENND4C(19357152)-RHOBTB2(22861937), # samples:2
Anticipated loss of major functional domain due to fusion event.DENND4C-RHOBTB2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DENND4C-RHOBTB2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:19357152/chr8:22861938)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DENND4C (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RHOBTB2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000434457DENND4Cchr919357152+ENST00000519685RHOBTB2chr822861938+8546538026675732435
ENST00000434457DENND4Cchr919357152+ENST00000522948RHOBTB2chr822861938+10297538026675732435
ENST00000602925DENND4Cchr919357152+ENST00000519685RHOBTB2chr822861938+8399523326674262386
ENST00000602925DENND4Cchr919357152+ENST00000522948RHOBTB2chr822861938+10150523326674262386
ENST00000380432DENND4Cchr919357152+ENST00000519685RHOBTB2chr822861938+730841423363352100
ENST00000380432DENND4Cchr919357152+ENST00000522948RHOBTB2chr822861938+905941423363352100
ENST00000434457DENND4Cchr919357152+ENST00000519685RHOBTB2chr822861937+8546538026675732435
ENST00000434457DENND4Cchr919357152+ENST00000522948RHOBTB2chr822861937+10297538026675732435
ENST00000602925DENND4Cchr919357152+ENST00000519685RHOBTB2chr822861937+8399523326674262386
ENST00000602925DENND4Cchr919357152+ENST00000522948RHOBTB2chr822861937+10150523326674262386
ENST00000380432DENND4Cchr919357152+ENST00000519685RHOBTB2chr822861937+730841423363352100
ENST00000380432DENND4Cchr919357152+ENST00000522948RHOBTB2chr822861937+905941423363352100

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000434457ENST00000519685DENND4Cchr919357152+RHOBTB2chr822861938+0.0007862130.9992138
ENST00000434457ENST00000522948DENND4Cchr919357152+RHOBTB2chr822861938+0.0008372620.9991628
ENST00000602925ENST00000519685DENND4Cchr919357152+RHOBTB2chr822861938+0.0008552560.9991447
ENST00000602925ENST00000522948DENND4Cchr919357152+RHOBTB2chr822861938+0.0009075750.99909246
ENST00000380432ENST00000519685DENND4Cchr919357152+RHOBTB2chr822861938+0.0006599970.99934
ENST00000380432ENST00000522948DENND4Cchr919357152+RHOBTB2chr822861938+0.0007017510.9992982
ENST00000434457ENST00000519685DENND4Cchr919357152+RHOBTB2chr822861937+0.0007862130.9992138
ENST00000434457ENST00000522948DENND4Cchr919357152+RHOBTB2chr822861937+0.0008372620.9991628
ENST00000602925ENST00000519685DENND4Cchr919357152+RHOBTB2chr822861937+0.0008552560.9991447
ENST00000602925ENST00000522948DENND4Cchr919357152+RHOBTB2chr822861937+0.0009075750.99909246
ENST00000380432ENST00000519685DENND4Cchr919357152+RHOBTB2chr822861937+0.0006599970.99934
ENST00000380432ENST00000522948DENND4Cchr919357152+RHOBTB2chr822861937+0.0007017510.9992982

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DENND4C-RHOBTB2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DENND4Cchr919357152RHOBTB2chr82286193741421362MDFPKHNQIITEETGSAVEPRSRLMD
DENND4Cchr919357152RHOBTB2chr82286193752331648MDFPKHNQIITEETGSAVEPRSRLMD
DENND4Cchr919357152RHOBTB2chr82286193753801697MDFPKHNQIITEETGSAVEPRSRLMD
DENND4Cchr919357152RHOBTB2chr82286193841421362MDFPKHNQIITEETGSAVEPRSRLMD
DENND4Cchr919357152RHOBTB2chr82286193852331648MDFPKHNQIITEETGSAVEPRSRLMD
DENND4Cchr919357152RHOBTB2chr82286193853801697MDFPKHNQIITEETGSAVEPRSRLMD

Top

Potential FusionNeoAntigen Information of DENND4C-RHOBTB2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DENND4C-RHOBTB2_19357152_22861937.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A66:01ETGSAVEPR0.99610.61921221
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A26:03ETGSAVEPR0.98220.66181221
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-B45:01EETGSAVEP0.95990.93681120
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-B50:02EETGSAVEP0.9240.7821120
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A34:01ETGSAVEPR0.7720.51961221
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A34:05ETGSAVEPR0.7720.51961221
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-B41:01EETGSAVEP0.23860.88451120
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-B45:01TEETGSAVEP0.92470.95251020
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A68:24EETGSAVEPR0.89850.52471121
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A68:03EETGSAVEPR0.89470.50891121
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A68:24ETGSAVEPRSR0.99820.74481223
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A68:03ETGSAVEPRSR0.99780.7171223
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C05:09ITEETGSAV0.99970.9866918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C08:15ITEETGSAV0.99830.9925918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C08:04ITEETGSAV0.41120.9881918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C08:13ITEETGSAV0.41120.9881918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C08:03ITEETGSAV0.13030.9944918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A68:01EETGSAVEPR0.89850.52471121
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-A68:01ETGSAVEPRSR0.99820.74481223
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C05:01ITEETGSAV0.99970.9866918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C04:03ITEETGSAV0.99960.9767918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C08:02ITEETGSAV0.99830.9925918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C03:06ITEETGSAV0.78410.9951918
DENND4C-RHOBTB2chr919357152chr8228619374142HLA-C08:01ITEETGSAV0.13030.9944918

Top

Potential FusionNeoAntigen Information of DENND4C-RHOBTB2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DENND4C-RHOBTB2_19357152_22861937.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0102NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0401HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0401KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0403HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0403KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0413HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0413KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0413NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0413PKHNQIITEETGSAV318
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0415HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0419HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0422HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0422KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0422NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0422PKHNQIITEETGSAV318
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0427HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0433HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0433KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0434HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0435HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0435KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0436HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0437HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0438HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0438KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0439HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0439KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0440HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0440KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0440NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0441HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0441KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0442HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0442KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0444HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0444KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0444NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0446HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0446KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0449HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0450HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0450KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0451HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0451KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0452HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0452KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0453HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0455HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0455KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0456HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0456KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0458HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0459HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0460HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0460KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0461HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0462HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0463HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0463KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0464HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0464KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0467HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0467KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0468HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0468KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0468NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0470HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0470KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0470NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0471HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0471KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0472HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0472KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0473HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0475HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0476HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0476KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0478HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0479HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0479KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0479NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0485HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0485KHNQIITEETGSAVE419
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-0488HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-1525HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB1-1525NQIITEETGSAVEPR621
DENND4C-RHOBTB2chr919357152chr8228619374142DRB4-0101HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB4-0103HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB4-0104HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB4-0106HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB4-0107HNQIITEETGSAVEP520
DENND4C-RHOBTB2chr919357152chr8228619374142DRB4-0108HNQIITEETGSAVEP520

Top

Fusion breakpoint peptide structures of DENND4C-RHOBTB2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6338NQIITEETGSAVEPDENND4CRHOBTB2chr919357152chr8228619374142

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DENND4C-RHOBTB2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6338NQIITEETGSAVEP-7.9962-8.1096
HLA-B14:023BVN6338NQIITEETGSAVEP-5.70842-6.74372
HLA-B52:013W396338NQIITEETGSAVEP-6.83737-6.95077
HLA-B52:013W396338NQIITEETGSAVEP-4.4836-5.5189
HLA-A11:014UQ26338NQIITEETGSAVEP-10.0067-10.1201
HLA-A11:014UQ26338NQIITEETGSAVEP-9.03915-10.0745
HLA-A24:025HGA6338NQIITEETGSAVEP-6.56204-6.67544
HLA-A24:025HGA6338NQIITEETGSAVEP-5.42271-6.45801
HLA-B44:053DX86338NQIITEETGSAVEP-7.85648-8.89178
HLA-B44:053DX86338NQIITEETGSAVEP-5.3978-5.5112
HLA-A02:016TDR6338NQIITEETGSAVEP-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of DENND4C-RHOBTB2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DENND4C-RHOBTB2chr919357152chr8228619371020TEETGSAVEPTGAACCAAGGTCCCGTTTAATGGATTCTGA
DENND4C-RHOBTB2chr919357152chr8228619371120EETGSAVEPACCAAGGTCCCGTTTAATGGATTCTGA
DENND4C-RHOBTB2chr919357152chr8228619371121EETGSAVEPRACCAAGGTCCCGTTTAATGGATTCTGACAT
DENND4C-RHOBTB2chr919357152chr8228619371221ETGSAVEPRAAGGTCCCGTTTAATGGATTCTGACAT
DENND4C-RHOBTB2chr919357152chr8228619371223ETGSAVEPRSRAAGGTCCCGTTTAATGGATTCTGACATGGATTA
DENND4C-RHOBTB2chr919357152chr822861937918ITEETGSAVAGTTGAACCAAGGTCCCGTTTAATGGA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
DENND4C-RHOBTB2chr919357152chr822861937318PKHNQIITEETGSAVTGAAGAAACAGGCTCTGCAGTTGAACCAAGGTCCCGTTTAATGGA
DENND4C-RHOBTB2chr919357152chr822861937419KHNQIITEETGSAVEAGAAACAGGCTCTGCAGTTGAACCAAGGTCCCGTTTAATGGATTC
DENND4C-RHOBTB2chr919357152chr822861937520HNQIITEETGSAVEPAACAGGCTCTGCAGTTGAACCAAGGTCCCGTTTAATGGATTCTGA
DENND4C-RHOBTB2chr919357152chr822861937621NQIITEETGSAVEPRAGGCTCTGCAGTTGAACCAAGGTCCCGTTTAATGGATTCTGACAT

Top

Information of the samples that have these potential fusion neoantigens of DENND4C-RHOBTB2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
PRADDENND4C-RHOBTB2chr919357152ENST00000380432chr822861937ENST00000519685TCGA-EJ-7785

Top

Potential target of CAR-T therapy development for DENND4C-RHOBTB2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to DENND4C-RHOBTB2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DENND4C-RHOBTB2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource